Medicine’s Rong Xu links semaglutide to lower Alzheimer’s risk in Type 2 diabetes patients
Drugs like Ozempic and Wegovy are linked to a lower risk of Alzheimer’s disease, new study says
Fortune Magazine: Rong Xu, professor at the School of Medicine, said semaglutide, the active ingredient in Ozempic and Wegovy, was associated with a 40% to 70% lower risk of Alzheimer’s diagnosis among nearly 1 million people with Type 2 diabetes, according to Case Western Reserve research. She cautioned that the findings show an association, not proof of prevention.